GrowingStockReport.com

Celldex Therapeutics, Inc. (NASDAQ:CLDX) and Synageva BioPharma Corp. (NASDAQ:GEVA) Added to Growing Stock Report's NASDAQ Gainers Watch List.

 
Repost This

New York, NY -- (SBWIRE) -- 08/05/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Celldex Therapeutics, Inc. (NASDAQ:CLDX) and Synageva BioPharma Corp. (NASDAQ:GEVA).

Celldex Therapeutics, Inc. (NASDAQ:CLDX) a biopharmaceutical company that focuses on the development, manufacture, and commercialization of novel therapeutics for human health care primarily in the United States is currently down (-0.44%) on 1,182,600 shares traded. Celldex Therapeutics, Inc. (NASDAQ:CLDX) is currently down (-5.09%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Celldex Therapeutics, Inc. (NASDAQ:CLDX)

Synageva BioPharma Corp. (NASDAQ:GEVA) a clinical stage biopharmaceutical company that focuses on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and unmet medical needs is currently up (+0.36%) on 6,024 shares traded. Synageva BioPharma Corp. (NASDAQ:GEVA) is currently up (+28.54%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Synageva BioPharma Corp. (NASDAQ:GEVA)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure: GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com